141 related articles for article (PubMed ID: 17630838)
1. Preferential gene transfer of lentiviral vectors to liver-derived cells, using a hepatitis B peptide displayed on GP64.
Markusic DM; Kanitz A; Oude-Elferink RP; Seppen J
Hum Gene Ther; 2007 Jul; 18(7):673-9. PubMed ID: 17630838
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
[TBL] [Abstract][Full Text] [Related]
3. Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus.
Kang JH; Toita R; Asai D; Yamaoka T; Murata M
J Virol Methods; 2014 Jun; 201():20-3. PubMed ID: 24568971
[TBL] [Abstract][Full Text] [Related]
4. Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain.
Markusic DM; van Til NP; Hiralall JK; Elferink RP; Seppen J
BMC Biotechnol; 2009 Oct; 9():85. PubMed ID: 19811629
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
6. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
Kumar M; Bradow BP; Zimmerberg J
Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
[TBL] [Abstract][Full Text] [Related]
7. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
8. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
[TBL] [Abstract][Full Text] [Related]
9. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
10. Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein.
Guibinga GH; Friedmann T
Mol Ther; 2005 Apr; 11(4):645-51. PubMed ID: 15771967
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
12. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
13. An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus.
Kim DH; Ni Y; Lee SH; Urban S; Han KH
BMB Rep; 2008 Sep; 41(9):640-4. PubMed ID: 18823587
[TBL] [Abstract][Full Text] [Related]
14. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody.
Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A
Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277
[TBL] [Abstract][Full Text] [Related]
15. GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice.
Milani M; Canepari C; Assanelli S; Merlin S; Borroni E; Starinieri F; Biffi M; Russo F; Fabiano A; Zambroni D; Annoni A; Naldini L; Follenzi A; Cantore A
EMBO Mol Med; 2024 Jun; 16(6):1427-1450. PubMed ID: 38684862
[TBL] [Abstract][Full Text] [Related]
16. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
[TBL] [Abstract][Full Text] [Related]
17. Targeting and purification of metabolically biotinylated baculovirus.
Kaikkonen MU; Viholainen JI; Närvänen A; Ylä-Herttuala S; Airenne KJ
Hum Gene Ther; 2008 Jun; 19(6):589-600. PubMed ID: 18479188
[TBL] [Abstract][Full Text] [Related]
18. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
Kumar M; Follenzi A; Garforth S; Gupta S
Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
[TBL] [Abstract][Full Text] [Related]
19. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
20. Human, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors.
Hornick AL; Li N; Oakland M; McCray PB; Sinn PL
Hum Gene Ther; 2016 May; 27(5):354-62. PubMed ID: 27004832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
